AZD1222 Vaccine for the Prevention of COVID-19
Is a
Allocation Type
NA
0
Health Conditions in Trial
Intervention Model
Single Group Assignment
0
Intervention Name
AZD1222
0
Interventional Trial Phase
Phase 3
Interventional Trial Purpose
Prevention
0
Intervention Type
Biological
Last Updated
October 1, 2021
0
Masking Type
None (Open Label)
0
Primary Completion Date
March 5, 2021
Trial Recruitment Size
100
Trial Recruitment Status
Not yet recruiting
Trial Sponsor
Clinical Trial Start Date
August 26, 2020
Study Completion Date
March 5, 2021
Clinical Trial Study Type
Interventional
NCT Number
Official Name
A Phase III Open-label Study in Adults to Determine the Safety and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-19
0
Official Website
Find more entities like AZD1222 Vaccine for the Prevention of COVID-19
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.